Altered gene expressions of ghrelin, PYY, and CCK in the gastrointestinal tract of the hyperphagic intrauterine growth restriction rat offspring.
Intrauterine growth restriction (IUGR) is associated with a substantially greater incidence of metabolic syndrome in adulthood. Animal studies have shown that IUGR offspring are hyperphagic during the early postnatal period and therefore exhibit obesity. The molecular mechanisms underlying food intake regulation in the gastrointestinal tract have not been clarified in IUGR. In the present study, we utilized a rat model of IUGR by restricting the food intake of the mother (50% of the normal intake, ad libitum; FR group) from day 7 of gestation until delivery. Pups from undernourished mothers were fostered by control mothers. We examined the food intake and assessed the gene expressions of ghrelin, peptide YY (PYY), and cholecystokinin (CCK) in the alimentary tract of male newborns (postnatal day1) and adult offspring (age, 7 months). Compared to the offspring whose mothers received the standard diet ad libitum (CON offspring), FR offspring were hyperphagic from the weaning time until the end of the experiment, and resulted in a heavier final weight. Both newborn and adult FR offspring had higher ghrelin gene expression in the stomach and higher ghrelin plasma levels than did the controls. Although the gastrointestinal gene expressions and plasma levels of the anorexic peptides, PYY and CCK, were elevated in the FR newborns, they decreased in the FR adults. Our findings suggest that the altered gene expressions of orexigenic and anorexigenic gut peptides in the gastrointestinal tract in the maternal undernutrition-induced IUGR offspring provide a potential mechanism to explain hyperphagia and obesity seen in these offspring.
Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan. amn_e@hama-med.ac.jp
E
E
Nagata
Y
Y
Nakagawa
R
R
Yamaguchi
Y
Y
Fujisawa
S
S
Sano
E
E
Satake
R
R
Matsushita
T
T
Nakanishi
Y
Y
Liu
T
T
Ohzeki
D000328:Adult; D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight; D002766:Cholecystokinin / Q000097:blood / Q000235:genetics*; D004195:Disease Models, Animal; D004435:Eating; D005260:Female; D005317:Fetal Growth Retardation / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D041981:Gastrointestinal Tract / Q000254:growth & development / Q000378:metabolism*; D015870:Gene Expression; D018507:Gene Expression Regulation, Developmental; D054439:Ghrelin / Q000097:blood / Q000235:genetics*; D006801:Humans; D006963:Hyperphagia / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D008297:Male; D019894:Peptide YY / Q000097:blood / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015854:Up-Regulation
D054439:Ghrelin; D019894:Peptide YY; D002766:Cholecystokinin